Loading...

XERS XERIS BIOPHARMA HOLDINGS INC Management Changes 8-K Filing

XRS

XRS

XERIS BIOPHARMA HOLDINGS INC

(XERS)

2024 8-K

Financial Results Update

Financial Results Update

Patent Notice Granted

Financial Results Report

Financial Statements

Financial Statements

Management Changes

Financial Results

Management Changes

Financial Results

Financial Results

Earnings Report

Promotion of Kevin McCulloch

Results of Operations and F...

Annual Meeting Approval

Results of Operations and F...

Credit Agreement and Result...

Earnings Reports

Financial Results Announcement

Material Definitive Agreement

Earnings Report

Annual Meeting of Stockholders

Earnings Reports

Appointment of Director

Dismissal of Independent Re...

Earnings Report

Amendment to Credit Agreeme...

Earnings Reports

External Links:

Xeris Biopharma Holdings, Inc. announced preliminary results for Q2 2024 and the departure of CEO Paul R. Edick, who will become a Senior Advisor, with John Shannon appointed as the new CEO.

AI Assistant

XERIS BIOPHARMA HOLDINGS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.